Geode Capital Management’s Strata Skin Sciences SSKN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-18,896
| Closed | -$23.8K | – | 4596 |
|
|
2025
Q4 | $23.8K | Buy |
18,896
+759
| +4% | +$1.2K | ﹤0.01% | 4364 |
|
|
2025
Q3 | $37.4K | Sell |
18,137
-56
| -0.3% | -$111 | ﹤0.01% | 4348 |
|
|
2025
Q2 | $41.9K | Sell |
18,193
-76
| -0.4% | -$190 | ﹤0.01% | 4247 |
|
|
2025
Q1 | $48.2K | Buy |
18,269
+1,407
| +8% | +$3.92K | ﹤0.01% | 4208 |
|
|
2024
Q4 | $48.7K | Hold |
16,862
| – | – | ﹤0.01% | 4247 |
|
|
2024
Q3 | $46.4K | Buy |
16,862
+2,119
| +14% | +$6.62K | ﹤0.01% | 4275 |
|
|
2024
Q2 | $45.3K | Buy |
14,743
+2,623
| +22% | +$10.6K | ﹤0.01% | 4301 |
|
|
2024
Q1 | $45.8K | Buy |
12,120
+1,058
| +10% | +$5.52K | ﹤0.01% | 4335 |
|
|
2023
Q4 | $60.9K | Hold |
11,062
| – | – | ﹤0.01% | 4303 |
|
|
2023
Q3 | $65.8K | Buy |
11,062
+7,002
| +172% | +$53.8K | ﹤0.01% | 4356 |
|
|
2023
Q2 | $38.6K | Hold |
4,060
| – | – | ﹤0.01% | 4561 |
|
|
2023
Q1 | $44.7K | Hold |
4,060
| – | – | ﹤0.01% | 4548 |
|
|
2022
Q4 | $32K | Hold |
4,060
| – | – | ﹤0.01% | 4698 |
|
|
2022
Q3 | $35K | Hold |
4,060
| – | – | ﹤0.01% | 4826 |
|
|
2022
Q2 | $39K | Hold |
4,060
| – | – | ﹤0.01% | 4825 |
|
|
2022
Q1 | $59K | Hold |
4,060
| – | – | ﹤0.01% | 4775 |
|
|
2021
Q4 | $59K | Hold |
4,060
| – | – | ﹤0.01% | 4831 |
|
|
2021
Q3 | $74K | Hold |
4,060
| – | – | ﹤0.01% | 4726 |
|
|
2021
Q2 | $62K | Hold |
4,060
| – | – | ﹤0.01% | 4629 |
|
|
2021
Q1 | $67K | Hold |
4,060
| – | – | ﹤0.01% | 4367 |
|
|
2020
Q4 | $60K | Hold |
4,060
| – | – | ﹤0.01% | 4137 |
|
|
2020
Q3 | $54K | Hold |
4,060
| – | – | ﹤0.01% | 4001 |
|
|
2020
Q2 | $46K | Hold |
4,060
| – | – | ﹤0.01% | 3986 |
|
|
2020
Q1 | $36K | Hold |
4,060
| – | – | ﹤0.01% | 3971 |
|
|
2019
Q4 | $84K | Buy |
4,060
+370
| +10% | +$8.4K | ﹤0.01% | 4007 |
|
|
2019
Q3 | $78K | Hold |
3,690
| – | – | ﹤0.01% | 4002 |
|
|
2019
Q2 | $91K | Buy |
3,690
+427
| +13% | +$10.7K | ﹤0.01% | 3983 |
|
|
2019
Q1 | $92K | Sell |
3,263
-2,333
| -42% | -$71K | ﹤0.01% | 3915 |
|
|
2018
Q4 | $144K | Sell |
5,596
-4,065
| -42% | -$116K | ﹤0.01% | 3769 |
|
|
2018
Q3 | $341K | Buy |
+9,661
| New | +$238K | ﹤0.01% | 3586 |
|
|
2017
Q2 | – | Sell |
-321
| Closed | -$9K | – | 4105 |
|
|
2017
Q1 | $9K | Hold |
321
| – | – | ﹤0.01% | 4061 |
|
|
2016
Q4 | $7K | Hold |
321
| – | – | ﹤0.01% | 4030 |
|
|
2016
Q3 | $8K | Hold |
321
| – | – | ﹤0.01% | 4020 |
|
|
2016
Q2 | $9K | Hold |
321
| – | – | ﹤0.01% | 4050 |
|
|
2016
Q1 | $15 | Hold |
321
| – | – | ﹤0.01% | 4071 |
|
|
2015
Q4 | $17K | Hold |
321
| – | – | ﹤0.01% | 4102 |
|
|
2015
Q3 | $18K | Hold |
321
| – | – | ﹤0.01% | 4092 |
|
|
2015
Q2 | $18K | Hold |
321
| – | – | ﹤0.01% | 3939 |
|
|
2015
Q1 | $41K | Hold |
321
| – | – | ﹤0.01% | 3872 |
|
|
2014
Q4 | $19K | Hold |
321
| – | – | ﹤0.01% | 3952 |
|
|
2014
Q3 | $27K | Hold |
321
| – | – | ﹤0.01% | 3887 |
|
|
2014
Q2 | $51K | Hold |
321
| – | – | ﹤0.01% | 3777 |
|
|
2014
Q1 | $100K | Hold |
321
| – | – | ﹤0.01% | 3665 |
|
|
2013
Q4 | $102K | Sell |
321
-2
| -0.6% | -$716 | ﹤0.01% | 3598 |
|
|
2013
Q3 | $117K | Hold |
323
| – | – | ﹤0.01% | 3467 |
|
|
2013
Q2 | $150K | Buy |
+323
| New | +$173K | ﹤0.01% | 3325 |
|
Geode Capital Management's SSKN Position: Q1 2026 in Review
Geode Capital Management sold out of Strata Skin Sciences (SSKN) in Q1 2026, closing a stake of 18,896 shares — an estimated $23.8K sold.
Geode Capital Management first reported a position in SSKN in Q2 2013 and held it in 46 quarters. The position peaked at $341K in Q3 2018. 0 funds tracked by Wall St. Rank hold SSKN as of Q1 2026.
- Geode Capital Management reported no remaining Strata Skin Sciences position as of Q1 2026 after selling out during the quarter.
- Geode Capital Management sold 18,896 Strata Skin Sciences shares in Q1 2026, an estimated $23.8K.
- Geode Capital Management first reported a position in Strata Skin Sciences in Q2 2013 and held it in 46 quarters.
- Geode Capital Management's Strata Skin Sciences position peaked at $341K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.